Healthcare earnings calendar for the week of February 19th
Monday, 19-February-2018
All conference call times Eastern. - Special thanks to @TomMathies for helping me compile this list. Very nice of him to take the time to do that.
Monday, February 19
Washington's Birthday Holiday
Tuesday, February 20
DelMar Pharmaceuticals (DMPI) - 4:30 PM
Halozyme (HALO) - 4:30 PM
Henry Schein (HSIC) - 10:00 AM
Medtronic (MDT) - 8:00 AM
Spark Therapeutics (ONCE) - 8:30 AM
TherapeuticsMD (TXMD) - 4:30 PM
Ultragenyx (RARE) - 5:00 PM
Wednesday, February 21
Blueprint Medicines (BPMC) - 8:30 AM
Compugen (CGEN) - 10:00 AM
Endologix (ELGX) - 4:30 PM
G1 Therapeutics (GTHX) - 4:30 PM
Genmab (GEN.CO) - 12:00 PM
Globus Medical (GMED) - 4:30 PM
Insulet Corporation (PODD) - 4:30 PM
LeMaitre Vascular (LMAT) - 5:00 PM
Ligand Pharmaceuticals (LGND) - 4:30 PM
The Medicines Company (MDCO) - 8:30 AM
Momenta Pharmaceuticals (MNTA) - 10:00 AM
NeoGenomics (NEO) - 10:00 AM
Quidel (QDEL) - 5:00 PM
Spring Bank Pharmaceuticals (SBPH) - 8:30 AM
United Therapeutics Corporation (UTHR) - 9:00 AM
Thursday, February 22
Adamas (ADMS) - 4:30 PM
Anika Therapeutics (ANIK) - 9:00 AM
BioMarin (BMRN) - 4:30 PM
BioTelemetry, Inc. (BEAT) - 5:00 PM
Corcept Therapeutics (CORT) - 5:00 PM
Emergent BioSolutions (EBS) - 5:00 PM
Exact Sciences (EXAS) - 5:00 PM
Integer Holdings Corporation (ITGR) - 5:00 PM
Lexicon Pharmaceuticals (LXRX) - 8:00 AM
Nevro (NVRO) - 4:30 PM
Novocure (NVCR) - 8:00 AM
PRA Health Sciences (PRAH) - 9:00 AM
RedHill Biopharma (RDHL) - 9:00 AM
Repligen (RGEN) - 8:30 AM
Sage Therapeutics (SAGE) - 8:00 AM
Sangamo Therapeutics (SGMO) - 8:00 AM
Select Medical Holdings Corporation (SEM) - 9:00 AM
Synthetic Biologics (SYN) - 8:30 AM
Teleflex (TFX) - 8:00 AM
Friday, February 23
Digirad Corporation (DRAD) - 11:00 AM
Galapagos (GLPG) - 8:00 AM
Insmed (INSM) - 8:30 AM
LifePoint Health (LPNT) - 10:00 AM
MiMedx operational update (MDXG) - 10:30 AM
Please let me know if I omitted any names and I'll be happy to add.
Who Am I?
I'm an individual investor from Kansas City. My focus is on biotech stocks, but I enjoy investing in all industries. I'm an old-school, buy and hold investor who believes the best way to outperform and grow capital is to own innovative companies with good management teams over the long-term. more>>>